Araksya Izmiryan
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype.
Journal: The Journal of experimental medicine
Published: January 10, 2026
Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa.
Journal: The Journal of investigative dermatology
Published: March 23, 2023
Generation and characterization of induced pluripotent stem cell lines from two patients with recessive dystrophic epidermolysis Bullosa.
Journal: Stem cell research
Published: March 20, 2023
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin.
Journal: Science (New York, N.Y.)
Published: May 19, 2022
Inactivation of vimentin in satellite glial cells affects dorsal root ganglion intermediate filament expression and neuronal axon growth in vitro.
Journal: Molecular and cellular neurosciences
Published: January 06, 2021
Emerging drugs for the treatment of epidermolysis bullosa.
Journal: Expert opinion on emerging drugs
Published: October 23, 2020
EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa.
Journal: The British journal of dermatology
Published: September 27, 2019
Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair.
Journal: Molecular therapy. Nucleic acids
Published: March 02, 2018
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System.
Journal: Molecular therapy. Nucleic acids
Published: November 12, 2016
Intermediate filaments in peripheral nervous system: Their expression, dysfunction and diseases.
Journal: Revue neurologique
Published: May 30, 2016
The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs.
Journal: The Journal of investigative dermatology
Published: October 28, 2015
Meganuclease-Mediated COL7A1 Gene Correction for Recessive Dystrophic Epidermolysis Bullosa.
Journal: The Journal of investigative dermatology
Published: July 28, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026